Twist Bioscience Corporation
TWST
$39.96
$0.842.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 330.19M | 312.97M | 295.21M | 277.49M | 262.36M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 330.19M | 312.97M | 295.21M | 277.49M | 262.36M |
| Cost of Revenue | 182.96M | 179.63M | 175.57M | 171.23M | 168.47M |
| Gross Profit | 147.23M | 133.35M | 119.64M | 106.26M | 93.89M |
| SG&A Expenses | 221.74M | 218.40M | 212.65M | 201.91M | 200.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 493.76M | 488.88M | 481.68M | 468.66M | 467.48M |
| Operating Income | -163.57M | -175.90M | -186.47M | -191.17M | -205.12M |
| Income Before Tax | -196.78M | -208.17M | -219.88M | -191.27M | -204.61M |
| Income Tax Expenses | 537.00K | 560.00K | 434.00K | 865.00K | 1.20M |
| Earnings from Continuing Operations | -197.31 | -208.73 | -220.31 | -192.14 | -205.80 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -197.31M | -208.73M | -220.31M | -192.14M | -205.80M |
| EBIT | -163.57M | -175.90M | -186.47M | -191.17M | -205.12M |
| EBITDA | -136.53M | -147.07M | -154.10M | -158.61M | -173.83M |
| EPS Basic | -3.38 | -3.60 | -3.81 | -3.35 | -3.60 |
| Normalized Basic EPS | -1.63 | -1.76 | -1.86 | -1.91 | -2.08 |
| EPS Diluted | -3.39 | -3.60 | -3.82 | -3.35 | -3.60 |
| Normalized Diluted EPS | -1.63 | -1.76 | -1.86 | -1.91 | -2.08 |
| Average Basic Shares Outstanding | 233.64M | 231.98M | 230.70M | 229.60M | 228.59M |
| Average Diluted Shares Outstanding | 233.64M | 231.98M | 230.70M | 229.60M | 228.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
